{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"}],"units":"Participants"}],"description":"EFS for very high risk (VHR) T-LLy patients treated with HR Berlin-Frankfurt-Munster (BFM) intensification blocks who have complete or partial remission and those who do not respond","dispersionType":"95% Confidence Interval","groups":[{"description":"VHR T-LLy patients who achieved complete or partial response (CR/PR) at the end of the high-risk blocks","id":"OG000","title":"VHR T-LLy (CR/PR)"},{"description":"VHR T-LLy patients who did not respond (NR) at the end of the high-risk blocks","id":"OG001","title":"VHR T-LLy (NR)"}],"paramType":"NUMBER","populationDescription":"VHR T-LL patients who completed the three high-risk blocks of therapy. The T-LLy VHR patients are included in the table, but there were not enough patients to do any formal analysis, eg there was only one patient (n=1) on the study with T-LLy who had radiographic disease assessment after the intensification blocks.","reportingStatus":"POSTED","timeFrame":"3 years","title":"EFS for Very High Risk (VHR) T-LLy Patients Treated With HR Berlin-Frankfurt-Munster (BFM) Intensification Blocks Who Have Complete or Partial Remission and Those Who do Not Respond","type":"SECONDARY","unitOfMeasure":"Percentage of participants"}